🇺🇸 FDA
Patent

US 6444650

Antisense compositions for detecting and inhibiting telomerase reverse transcriptase

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6444650 (Antisense compositions for detecting and inhibiting telomerase reverse transcriptase) held by The Regents of the University of Technology Office of Technology Transfer expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Technology Office of Technology Transfer
Grant date
Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00